Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

141.07 -0.64 (-0.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 811,970
Open 140.96
Bid (Size) 141.07 (100)
Ask (Size) 141.20 (100)
Prev. Close 141.71
Today's Range 139.26 - 142.84
52wk Range 95.49 - 148.06
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Top 5 Analyst Questions From Jazz Pharmaceuticals’s Q3 Earnings Call
Jazz Pharmaceuticals delivered a quarter that exceeded Wall Street’s expectations, with management attributing results to robust demand for Xywav and Epidiolex, as well as the swift and successful... 
Via StockStory
Topics Earnings
News headline image
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks

Performance

YTD
+14.0%
+14.0%
1 Month
+3.9%
+3.9%
3 Month
+19.8%
+19.8%
6 Month
+29.4%
+29.4%
1 Year
+13.5%
+13.5%

More News

Read More
News headline image
JAZZ Q3 Deep Dive: New Drug Launches and Portfolio Expansion Drive Strong Results
Via StockStory
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
Retail Traders Cheer Jazz Pharma After FDA Clears Rare Drug For Brain Tumor ↗
Via Stocktwits
News headline image
Jazz Pharma (JAZZ) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Jazz Pharmaceuticals’s (NASDAQ:JAZZ) Q3: Beats On Revenue
Via StockStory
Topics Supply Chain
News headline image
Insights into Jazz Pharmaceuticals's Upcoming Earnings ↗
Via Benzinga
News headline image
Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q3 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
1 Unprofitable Stock with Promising Prospects and 2 Facing Headwinds
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Sell JAZZ and 1 Stock to Buy Instead
Via StockStory
Topics Government Stocks World Trade
News headline image
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗
Via Benzinga
News headline image
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
Via MarketMinute
Topics Intellectual Property
News headline image
Deep Dive Into Jazz Pharmaceuticals Stock: Analyst Perspectives (9 Ratings) ↗
Via Benzinga
News headline image
3 Small Cap Stocks To Play As The Bantamweights Break Out On Wall Street ↗
Via Benzinga
News headline image
3 Cash-Producing Stocks We Approach with Caution
Via StockStory
News headline image
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
Via Benzinga
News headline image
SciSparc And AutoMax Call Off Merger ↗
Via Benzinga
News headline image
FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape
Via MarketMinute
News headline image
Deep Dive Into Jazz Pharmaceuticals Stock: Analyst Perspectives (9 Ratings) ↗
Via Benzinga
News headline image
Beyond The Numbers: 5 Analysts Discuss Jazz Pharmaceuticals Stock ↗
Via Benzinga
News headline image
Q2 Rundown: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Other Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
JAZZ Q2 Deep Dive: Pipeline Milestones and Oncology Headwinds Shape Outlook
Via StockStory
News headline image
Why Jazz Pharmaceuticals (JAZZ) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence
News headline image
Jazz (JAZZ) Q2 Revenue Rises 2% ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 141.07
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 11/14/25 04:00 PM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 8.79B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.